These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 6947410

  • 1. Phosphate metabolism in renal stone formers. (I): Indices of phosphate handling in calcium stone patients and healthy subjects.
    Wikström B, Backman U, Danielson BG, Fellström B, Hellsing K, Johansson G, Ljunghall S.
    Scand J Urol Nephrol Suppl; 1981; 61():I:1-18. PubMed ID: 6947410
    [Abstract] [Full Text] [Related]

  • 2. Phosphate metabolism in renal stone formers. (II): Relation to renal tubular functions and calcium metabolism.
    Wikström B, Backman U, Danielson BG, Fellström B, Johansson G, Ljunghall S, Wide L.
    Scand J Urol Nephrol Suppl; 1981; 61():II:1-26. PubMed ID: 6274002
    [Abstract] [Full Text] [Related]

  • 3. Phosphate metabolism and renal calcium stone disease.
    Wikström B.
    Scand J Urol Nephrol Suppl; 1981; 61():1-56. PubMed ID: 6274003
    [Abstract] [Full Text] [Related]

  • 4. Simplified protocol for biochemical evaluation of recurrent renal calcium stone disease.
    Thode J, Finnerup B, Parvin C, Holmegaard SN, Skaarup P, Sørensen OH, Transbøl I.
    Miner Electrolyte Metab; 1988; 14(5):288-96. PubMed ID: 2845241
    [Abstract] [Full Text] [Related]

  • 5. Renal phosphate control as a reliable predictive factor of stone recurrence.
    Kim YJ, Kim TH, Yun SJ, Kim ME, Kim WJ, Lee SC.
    J Urol; 2009 Jun; 181(6):2566-72; discussion 2572. PubMed ID: 19375105
    [Abstract] [Full Text] [Related]

  • 6. [Renal tubular function in children with hypercalciuria].
    Kovacević L, Kovacević S, Smoljanić Z, Kostić M, Peco-Antić A, Gajić M, Kovacević M, Jovanović O.
    Srp Arh Celok Lek; 1998 Jun; 126(7-8):223-7. PubMed ID: 9863386
    [Abstract] [Full Text] [Related]

  • 7. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M.
    Scand J Urol Nephrol Suppl; 1989 Jun; 119():1-53. PubMed ID: 2669121
    [Abstract] [Full Text] [Related]

  • 8. Effect of acute acid loading on acid-base and calcium metabolism.
    Osther PJ.
    Scand J Urol Nephrol; 2006 Jun; 40(1):35-44. PubMed ID: 16452054
    [Abstract] [Full Text] [Related]

  • 9. Case-control study of risk factors for idiopathic calcium nephrolithiasis.
    Wasserstein AG, Stolley PD, Soper KA, Goldfarb S, Maislin G, Agus Z.
    Miner Electrolyte Metab; 1987 Jun; 13(2):85-95. PubMed ID: 3696092
    [Abstract] [Full Text] [Related]

  • 10. Magnesium metabolism in renal stone disease.
    Johansson G, Backman U, Danielson BG, Ljunghall S, Wikström B.
    Invest Urol; 1980 Sep; 18(2):93-6. PubMed ID: 7410037
    [Abstract] [Full Text] [Related]

  • 11. Renal threshold phosphate concentration in patients with idiopathic nephrolithiasis: correlations with tubular functions, serum parathyroid hormone and 1,25(OH)2D3.
    Pabico RC, McKenna BA, Freeman RB.
    Proc Eur Dial Transplant Assoc; 1983 Sep; 20():450-4. PubMed ID: 6689210
    [Abstract] [Full Text] [Related]

  • 12. [Evidence for a glucose-dependent renal phosphorus leak in normo- and hypercalciuric stone-formers (author's transl)].
    Aubert J, Ulmann A, Lacour B, Bader C, Funck-Brentano JL.
    Nephrologie; 1980 Sep; 1(4):159-62. PubMed ID: 6895406
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A study of dietary calcium and other nutrients in idiopathic renal calcium stone formers with low bone mineral content.
    Trinchieri A, Nespoli R, Ostini F, Rovera F, Zanetti G, Pisani E.
    J Urol; 1998 Mar; 159(3):654-7. PubMed ID: 9474119
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Distal renal tubular acidosis in recurrent renal stone formers.
    Osther PJ, Hansen AB, Røhl HF.
    Dan Med Bull; 1989 Oct; 36(5):492-3. PubMed ID: 2805826
    [Abstract] [Full Text] [Related]

  • 19. Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation.
    Falkiewicz K, Kamińska D, Nahaczewska W, Boratyńska M, Owczarek H, Klinger M, Woźniak M, Patrzałek D, Szyber P.
    Transplant Proc; 2006 Oct; 38(1):119-22. PubMed ID: 16504680
    [Abstract] [Full Text] [Related]

  • 20. Metabolic studies in kidney stone disease.
    Wong SY, Slater SR, Evans RA, Mason R, Lancaster EK, Acland SM, Eade Y, Hills E, Dunstan CR.
    Q J Med; 1992 Mar; 82(299):247-58. PubMed ID: 1631259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.